Abstract
Pregabalin was first approved of pain relief to fibromyalgia (FM) in 2012, and then duloxetine in 2015. Medications for FM are gradually evaluated in Japan. In this symposium, clinical experiences were introduced in 300 FM patients with the main emphasis on medication. In usual drug therapy, pregabalin and neurotropin® are used as the first choice. Pregabalin will not be chosen in children, students, drivers, and instructors of precision machine. In these cases, usually high doses (double doses) neurotropin® are used at first, which are followed by combined use of clonazepam, duloxetine, mirtazapine, tramadol, and regnite®. The author, however, does not rely only on medications, and practices trigger point injection, warming therapy, alternative therapy, exercise, consulting therapy, and cognitive behavior therapy depending on different situations. In conclusion, tailor-made medicine is necessary for FM patients because they are heterozygous.
